Spironolactone
Brands: Aldactone · Spironolactone
23 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 40 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Brands: Aldactone · Spironolactone
Average across 40 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 60 | SUPPLYING |
| Proficient Rx LP | repackager | 19 | SUPPLYING |
| Zydus Lifesciences Limited | generic | 18 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | generic | 18 | SUPPLYING |
| Jubilant Cadista Pharmaceuticals Inc. | unknown | 14 | SUPPLYING |
| Asclemed USA, Inc. | repackager | 13 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 12 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 12 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | repackager | 8 | SUPPLYING |
| A-S Medication Solutions | repackager | 8 | SUPPLYING |
| Northwind Health Company, LLC | repackager | 8 | SUPPLYING |
| Accord Healthcare Inc. | generic | 7 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | repackager | 7 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 6 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 5 | SUPPLYING |
+ 8 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Spironolactone Tablet — reported in shortage by Pfizer Inc.. Therapeutic category: Cardiovascular.
Spironolactone Tablet — reported in shortage by Pfizer Inc.. Therapeutic category: Cardiovascular.
Presence of foreign substance: identified as aluminum. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — USA Nationwide
Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site. — Recalling firm: Pfizer Us Pharmaceutical Group — US Nationwide